about wellinks

Mission and Vision Statement

At Wellinks, we leverage our empathic and innovative spirit as a catalyst for creating a constellation of care around our members. Through virtual-first human-centered care, we empower greater outcomes for those living with chronic respiratory disease.

1

We are principled, ethical and honest. We choose integrity, regardless of challenges or difficulties.

2

We are effective and results-oriented. We say what we'll do and do what we say.

3

We are affirming and inclusive. We celebrate diversity in brains, bodies, and beliefs.

4

We are collaborative and cohesive. We empower our teammates and grow together.

5

We are impactful. We take courageous action in our pursuit to improve lives.

6

We are authentic. We empower open conversation and act according to facts.

People

Executive team
Alex Waldron - Chief Executive Officer (CEO)

Alex Waldron

Chief Executive Officer

Geoff Matous - President

Geoff Matous

President and Chief Commercial Officer

Ellen Su - Chief Product Officer

Ellen Su

Chief Product Officer

Ryan McMillian - Chief Financial Officer

Ryan McMillian

Chief Financial Officer

Abi Sundaramoorthy MD

Chief Medical Officer

board of directors
Kevin Rakin - Chair of the Board

Kevin Rakin

Chair of the Board

Henry Weinstein - Director

Henry Weinstein

Director

Steven Bruso

Director

Alex Waldron - Chief Executive Officer (CEO)

Alex Waldron

Chief Executive Officer

Wellinks has 5 years of experience building towards full-stack COPD Management.

2017
FDA Clearance and Launch of Flyp Nebulizer
Manufacturing at scale. CVS Health HUBs
2018
2019
$1M Device Revenue>20.000 COPD Customers
1st Integrated Virutal COPD Solutions
2020
2021
1st Clinical Study Complete & First IDN Partnership
Full Stack COPD Management
2022
Flyp Logo